Kyle Malady joined the Dexcom Board of Directors in 2020. Mr. Malady currently serves as executive vice president of global networks and technology & chief technology officer at Verizon Communications Inc. In this role, Mr. Malady leads the company’s network operations, IT functions, data center management, and customer facing new product realization.
Prior to assuming this role, Mr. Malady was head of the Core Engineering and Operations organization within the Global Network and Technology organization. He has also served as Verizon’s vice president of New Product Development, including an instrumental role in the development and commercialization of 4G LTE
In addition to his experience at Verizon, Mr. Malady manages Caelens Fund, a charity that raises money to provide free cardiac surgeries for children in developing countries. Mr. Malady holds an MBA in finance from the NYU Stern School of Business and Bachelor of Science in Mechanical Engineering from the University of Bridgeport.